AVANOS MEDICAL, INC. AVNS

About AVANOS MEDICAL, INC. (AVNS): stock profile, AI score and financials

Acquired by American Industrial Partners: AVANOS MEDICAL, INC. (AVNS) no longer trades and has left 13F Pro's AI-ranked universe. The acquisition closed on July 30, 2026 (SEC 8-K 2.01). Its last closing price was on July 24, 2026. It has left the AI-ranked universe. The score and rank below are its final ones, from July 1, 2026. AVANOS MEDICAL, INC. (AVNS) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro tracks AVNS using direct SEC EDGAR data and AI-powered research tools. Based on the latest XBRL financial filings (Q1 2026), AVANOS MEDICAL, INC. reports quarterly revenue of $182.2M, net income of $5.1M, an operating margin of 4.9%. Top institutional holders of AVNS by reported 13-F value include BlackRock, NEXPOINT ASSET MANAGEMENT, L.P., STATE STREET, based on the most recent SEC filings. AVNS trades on the NYSE exchange and files with the SEC under CIK 1606498. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate AVNS daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for AVANOS MEDICAL, INC. directly from SEC EDGAR.

Financials through the period ended Mar 31, 2026SEC EDGAR: CIK 1606498 →